Shanghai Henlius Biotech Inc - Co's New Drug Application of Innovative Small Molecular Hlx99 ("Hlx99") Was Approved by U.S. FDA
THOMSON REUTERS02-10
Shanghai Henlius Biotech Inc - Co's New Drug Application of Innovative Small Molecular Hlx99 ("Hlx99") Was Approved by U.S. FDA
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
抱歉,当前请求异常(-1)
Li-S Energy Ltd - Collaboration With Kea Aerospace to Power High Altitude Uavs
Eurogroup Laminations Spa - Consolidated Revenues for 2024 Amounted to EUR 869.4 Mln
Eurogroup Laminations Spa - Adjusted Ebitda for 2024 Stood at EUR 116 Mln
Eurogroup Laminations Spa - Group Revenues Expected to Grow With a Cagr of 10%-15% Over 2025-2028
Eurogroup Laminations Spa - Proposed Dividend of EUR 0.042 per Share
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial